Bill to Encourage Development of Zika Vaccine Awaits President Obama’s Signature

April 14, 2016

Bill to Add Zika to FDA's Priority Review Voucher Program Awaits Final Signaure from President Obama

On Tuesday, April 12, the US House of Representatives approved a bipartisan bill to speed the development of a treatment for the Zika virusThe bill was introduced by US Rep. G. K. Butterfield (D – NC) and U.S. Sen. Al Franken (D – MN), and according to the White House, is expected to be signed by President Obama.

If passed, the bill will add Zika to FDA's priority review voucher program, which would help provide drug makers with an incentive to develop a vaccine for the virus.  This program encourages companies to develop less cost-effective treatments for diseases that would not otherwise be attractive, and in exchange FDA reward the company by expediting the review of a more profitable drug in its pipeline.

The bill, which was passed by the Senate on March 17th, was approved by Congress on a voice vote.  According to an article from Reuters, White House spokeswoman Katie Hill called this a “small step” that could encourage pharmaceutical companies to attempt to develop a treatment for Zika.

Agency Alerts

January 27, 2016

Sanders Places Hold on Obama’s Nominee for FDA Commissioner

In September 2015, President Obama nominated Robert Califf, MD, a world renowned cardiologist and clinical trial expert, to serve as the next FDA Commissioner. Following his nomination, Dr. Califf...

Read the Full Article
Agency Alerts General Regulatory

December 9, 2016

Last Stop: President Obama – 21st Century Cures Bill Passes Through the Senate and Heads to Obama for Signature

After passing through the House of Representatives with an extraordinary amount of support last week, the 21st Century Cures Act headed to the Senate on Monday, December 5th. On Wednesday, December...

Read the Full Article
Agency Alerts General Regulatory

November 11, 2015

There’s an App for That: FDA Launches Orange Book Express App

On November 9, 2015, FDA launched the Orange Book Express application, which provides a list of the drug products approved by the FDA. What is the Orange Book? The Drug Price Competition and Patent...

Read the Full Article